{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:13:29Z","timestamp":1786997609835,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.transci.2024.103873","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T23:22:44Z","timestamp":1705015364000},"page":"103873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method"],"prefix":"10.1016","volume":"63","author":[{"given":"Hana","family":"Safi\u0107 Stani\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zrinka","family":"Kruhonja Gali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Luki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasna","family":"Bingulac-Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Juki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.103873_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02616","article-title":"Blood transfusion management for patients treated with anti-CD38 monoclonal antibodies","volume":"9","author":"Lancman","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2024.103873_bib2","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1111\/trf.16736","article-title":"alloimmunization and Daratumumab: are efforts to eliminate interferences and prevent new antibodies necessary?","volume":"61","author":"Lee","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103873_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4103\/GJTM.GJTM_78_20","article-title":"Resolving crossmatch incompatibility due to Daratumumab in multiple myeloma","volume":"5","author":"Amuragaa","year":"2020","journal-title":"Glob J Transfus Med"},{"key":"10.1016\/j.transci.2024.103873_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.21307\/immunohematology-2019-025","article-title":"Dithiothreitol treatment of red blood cells","volume":"33","author":"Buub","year":"2017","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2024.103873_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/tme.12808","article-title":"Alloimmunisation rate of patients on Daratumumab: a retrospective cohort study of patients in England","volume":"31","author":"Bullock","year":"2021","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103873_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/trf.17253","article-title":"Mitigation of therapeutic anti-CD38 antibody interference with fab fragments: How well does it perform?","author":"Habicht","year":"2023","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103873_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/vox.12653","article-title":"Vox Sanguinis International Forum on typing and matching strategies in patients on anti-CD38 monoclonal therapy: summary","volume":"113","author":"De Vooght","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103873_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/tme.12508","article-title":"Papain-treated panels are a simple method for the identification of allonatibodies in multiple myeloma patients treated with anti-CD38-based therapies","volume":"29","author":"Carreno-Tarragona","year":"2019","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103873_bib9","unstructured":"British Society for Haematology: Addendum to the PreTransfusion Compatibility Procedures in Blood Transfusion Laboratories, 2017 www.b-s-h.org.uk. Accessed on December 15th, 2023."},{"issue":"2","key":"10.1016\/j.transci.2024.103873_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/0973-6247.214358","article-title":"Interference of Daratumumab with pretransfusion testing, mimicking a high-titer, low avidity like antibody","volume":"11","author":"Lin","year":"2017","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.transci.2024.103873_bib11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/trf.13069","article-title":"Resolving the Daratumumab interference with blood compatibility testing","volume":"55","author":"Chapuy","year":"2015","journal-title":"Transfusion"},{"issue":"13","key":"10.1016\/j.transci.2024.103873_bib12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with Daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"N Eng J Med"},{"key":"10.1016\/j.transci.2024.103873_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/trf.13150","article-title":"When blood transfusion medicine becomes complicated due to intereference by monoclonal antibody therapy.","volume":"55","author":"Oostendorp","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103873_bib14","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood-2016-11-749432","article-title":"Daratumumab (anti-CD38) induces loss of CD38 on red blood cells","volume":"129","author":"Sullivan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.transci.2024.103873_bib15","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1111\/trf.16687","article-title":"Antibody incidence and red blood cell transfusions in patients on Daratumumab","volume":"61","author":"Tauscher","year":"2021","journal-title":"Transfusion"},{"issue":"22","key":"10.1016\/j.transci.2024.103873_bib16","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood.V128.22.1463.1463","article-title":"Determination of red blood cell alloimmunization rates in transfused patients with hematologic and oncologic malignancies","volume":"128","author":"Asare","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.transci.2024.103873_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/vox.12864","article-title":"Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab","volume":"115","author":"Ye","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103873_bib18","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/trf.16425","article-title":"Optimizing transfusion management of multiple myeloma patients receiving Daratumumab-based regimens","volume":"61","author":"Phou","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103873_bib19","first-page":"377","article-title":"Prijetransfuzijsko ispitivanje I transfuzijsko lije\u010denje pri primjeni monoklonksog protutijela anti-CD38","volume":"142","author":"Raos","year":"2020","journal-title":"Lije\u010d Vjesn"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050224000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T01:47:05Z","timestamp":1712195225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050224000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1473050224000053"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103873","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103873"}}